Navigation Links
Veran Medical Publishes Lung Cancer Patient Management Study
Date:7/11/2014

ST. LOUIS, July 11, 2014 /PRNewswire/ -- Veran Medical Technologies, a U.S. based medical device company, announced today the positive, cost-effective final results for the initial study of its innovative SPiNPerc™ procedure. The SPiNPerc endobronchial percutaneous biopsy study results support the use of a percutaneous approach to biopsy when a traditional bronchoscopic method is not possible.  Hospitals, patients and physicians experience positive financial outcomes when more can be accomplished in one procedure.  This study demonstrated a hospital savings of $693,327 per 200 lung cancer screening patients with positive findings.1

Photo - http://photos.prnewswire.com/prnh/20140710/126171 

Photo - http://photos.prnewswire.com/prnh/20140710/126170

In addition to the study, a SPiNPerc clinical trial is in process at Johns Hopkins Hospital in Baltimore, Maryland.  An interim analysis has shown the procedure to be feasible and safe with final data to be published in the near future.  Dr. Lonny Yarmus, Clinical Chief of the Division of Pulmonary and Critical Care at Johns Hopkins, stated that, "Veran's SPiNPerc technology gives me the option of an endobronchial and percutaneous approach to detect lung cancer.  Many of my patients in the study previously would have needed additional visits to get an answer."

Rob Powers, Veran's Global Vice President of Marketing, noted that, "ENB has been on the market for nearly 10 years and the five-year survival rate remains an unacceptable 15-16%.  We are providing both an advanced ENB system and innovations like SPiNPerc that have the potential to impact survival." Powers went on to add, "setting up a comprehensive lung cancer screening program is important.  The SPiNPerc procedure clearly offers a cost effective new patient care pathway for those patients with a suspicious lesion found on their CT scan."

The Lung Cancer Management study was written by Dr. K. Adam Lee, Dr. Abhijit A. Raval and Leah Amir. Practice points conclude that "having both navigation bronchoscopy and computed tomography fine-needle aspiration ready on the same platform allows an easy transition from one procedure to the other if the first approach fails."

Dr. K. Adam Lee, thoracic surgeon and expert in the SPiNPerc procedure, said that, "besides the cost effectiveness of SPiNPerc, Veran's technology gives me every tool I need to diagnosis and treat my patient in the best way, which demonstrates the practice of good medicine."

About Veran Medical Technologies. Veran Medical Technologies is a privately held soft tissue navigation company based in the USA, focused on the early diagnosis of cancer.  Multiple specialties use Veran's electromagnetic navigation platform to enhance hospital oncology programs.  The technology is used to assist with lung, kidney and liver procedures endobronchially or percutaneously for biopsies, ablations, drainages and more.   Veran Medical Technologies is headquartered in St. Louis, MO.

Veran Medical Technologies Media Contact

Michelle Kalz, Marketing Manager | 314.659.8500 | www.veranmedical.com

1 Lung Cancer Management, Lee, Raval, et. al 2014


'/>"/>
SOURCE Veran Medical Technologies
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. Veran Medical Technologies Welcomes New Member to its Board of Directors
2. CVBT-Aktionäre stimmen für Veränderungen
3. Astute Medical, Inc., veranstaltet Symposium aus anlaß des Critical Care Nephrology Kongress
4. CIOs von GlaxoSmithKline und British American Tobacco als Referenten auf führender Strategie-Veranstaltung für Unternehmensmobilität
5. Marken richtet branchenspezifische Diskussionsveranstaltung in Mexiko-Stadt aus
6. Noverant Launches Major Learning Management System Upgrade
7. University Hospitals Case Medical Center Awarded $4.7 Million Grant from U.S. Department of Health and Human Services
8. Representative Patrick Kennedy visits Mobergs medical device facility to discuss improvement in brain injury care
9. Ventana Medical Systems, Inc. and Merck KGaA, Darmstadt, Germany to develop companion diagnostic test for cancer treatment
10. Intellectual Property Insurance for Medical-related Products and Services
11. Tegra Medical Appoints New Chief Executive Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
(Date:6/23/2016)... Roche (SIX: RO, ROG; OTCQX: RHHBY) announced that it ... (procalcitonin) assay as a dedicated testing solution for people ... Roche is the first IVD company in the U.S ... assessment and management. PCT is a sepsis-specific ... blood can aid clinicians in assessing the risk of ...
(Date:6/23/2016)... , , , WHEN: , , ... , , , LOCATION: , , , Online, with free registration ... PANELISTS:  , , , Frost & Sullivan,s Global Vice President of ... Analyst, Divyaa Ravishankar and Unmesh Lal, Program Manager , ... witnessing an exceptional era. Several new demand spaces, such as innovative ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... Austin residents seeking Mohs surgery services, ... Mohs Surgery and to Dr. Russell Peckham for medical and surgical dermatology. , Dr. ... skin cancer. The selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
Breaking Medicine News(10 mins):